Roflumilast
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 995 publications
The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study.
Journal: JAAD case reports
Published: March 19, 2026
Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.
Journal: Seminars in respiratory and critical care medicine
Published: March 17, 2026
Favism crisis triggered by roflumilast therapy.
Journal: Revista clinica espanola
Published: March 13, 2026
Enhancement of memory network activity in schizophrenia patients by phosphodiesterase-4 (PDE4) inhibitor, roflumilast: A pilot study.
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 11, 2026
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.
Journal: Journal of drugs in dermatology : JDD
Published: March 11, 2026
Innovation in pediatric atopic dermatitis care: examining emerging topical treatment options.
Journal: Expert review of clinical pharmacology
Published: March 11, 2026
Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I - Nonscarring Disorders.
Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I - Nonscarring Disorders.
Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026
The dual potential of topical roflumilast: advancing psoriasis therapy and pioneering oral mucosal disease treatment.
Journal: Immunopharmacology and immunotoxicology
Published: March 02, 2026
Drugs for atopic dermatitis.
Journal: The Medical letter on drugs and therapeutics
Published: February 23, 2026
Comparison chart: Topical nonsteroidal drugs for atopic dermatitis.
Journal: The Medical letter on drugs and therapeutics
Published: February 23, 2026
Phosphodiesterase-4 Inhibitors in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Current Therapeutics, and Future Perspectives.
Journal: Cell biochemistry and biophysics
Published: February 12, 2026
Topical roflumilast 0.3% cream for mild hidradenitis suppurativa: A prospective case series.
Journal: JAAD case reports
Published: February 12, 2026
Last Updated: 04/28/2026